←Back to Expert Scholars
Translational Medicine / 转化医学Marginal Zone Lymphoma
Thomas Witzig
MD
🏢Mayo Clinic🌐USA
Professor of Medicine, Division of Hematology
100
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Thomas Witzig has led key clinical trials in marginal zone and follicular lymphomas at Mayo Clinic including development of lenalidomide and radioimmunotherapy approaches. His research has defined modern treatment paradigms for indolent B cell lymphomas.
Share:
🧪Research Fields 研究领域
marginal zone lymphoma
indolent lymphoma
lenalidomide
radioimmunotherapy
follicular lymphoma
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Thomas Witzig 的研究动态
Follow Thomas Witzig's research updates
留下邮箱，当我们发布与 Thomas Witzig（Mayo Clinic）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment